C-MER Eye Care Holdings Limited
Simbolis: 3309.HK
HKSE
3.11
HKDRinkos kaina šiandien
62.7191
P/E santykis
0.0000
PEG koeficientas
3.87B
MRK kapitalizacija
- 0.00%
DIV pajamingumas
C-MER Eye Care Holdings Limited (3309-HK) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 557.4 | 698.5 | 442.4 | ||||||||||
balance-sheet.row.short-term-investments | 0 | 44.7 | 53.8 | 55.7 | ||||||||||
balance-sheet.row.net-receivables | 0 | 66.7 | 53.9 | 30.1 | ||||||||||
balance-sheet.row.inventory | 0 | 42 | 55.6 | 34.5 | ||||||||||
balance-sheet.row.other-current-assets | 0 | 54.1 | 48.6 | 239.5 | ||||||||||
balance-sheet.row.total-current-assets | 0 | 720.1 | 856.6 | 746.4 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1000.3 | 1057.6 | 901.3 | ||||||||||
balance-sheet.row.goodwill | 0 | 530.4 | 540.7 | 195 | ||||||||||
balance-sheet.row.intangible-assets | 0 | 558.2 | 821.4 | 204 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1088.6 | 1362.1 | 398.9 | ||||||||||
balance-sheet.row.long-term-investments | 0 | 193.1 | 129.2 | 77.4 | ||||||||||
balance-sheet.row.tax-assets | 0 | 6.8 | 6.9 | 11 | ||||||||||
balance-sheet.row.other-non-current-assets | 0 | -260.3 | -510.7 | -179.1 | ||||||||||
balance-sheet.row.total-non-current-assets | 0 | 2028.5 | 2045.1 | 1209.5 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 0 | 2748.6 | 2901.7 | 1955.9 | ||||||||||
balance-sheet.row.account-payables | 0 | 54.9 | 45.3 | 39.9 | ||||||||||
balance-sheet.row.short-term-debt | 0 | 116.5 | 149.3 | 265.5 | ||||||||||
balance-sheet.row.tax-payables | 0 | 24 | 18.9 | 8.5 | ||||||||||
balance-sheet.row.long-term-debt-total | 0 | 13.8 | 21.2 | 7.6 | ||||||||||
Deferred Revenue Non Current | 0 | 232.7 | 281.9 | 198.6 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 0 | 163.7 | 290.7 | 92.2 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 366 | 378.6 | 210.4 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 232.7 | 281.9 | 198.6 | ||||||||||
balance-sheet.row.total-liab | 0 | 755.3 | 903.4 | 618.6 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 1520.5 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 0 | 125.6 | 126.7 | 115 | ||||||||||
balance-sheet.row.retained-earnings | 0 | 77.4 | 26.6 | 50.5 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -3.1 | 9.6 | 79 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 125.6 | 1703.2 | 1086.7 | ||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 1845.8 | 1866.1 | 1331.2 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2748.6 | 2901.7 | 1955.9 | ||||||||||
balance-sheet.row.minority-interest | 0 | 147.5 | 132.2 | 6 | ||||||||||
balance-sheet.row.total-equity | 0 | 1993.3 | 1998.2 | 1337.2 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||
Total Investments | 0 | 237.7 | 183 | 133.1 | ||||||||||
balance-sheet.row.total-debt | 0 | 363 | 452.5 | 471.7 | ||||||||||
balance-sheet.row.net-debt | 0 | -149.8 | -192.2 | 85 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 62 | -21.9 | 21.9 | ||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 223.7 | 148.6 | ||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -483.2 | -309.4 | ||||||||||
cash-flows.row.stock-based-compensation | 0 | 0.1 | 1.3 | 4.3 | ||||||||||
cash-flows.row.change-in-working-capital | 0 | 0 | -32.7 | -7.4 | ||||||||||
cash-flows.row.account-receivables | 0 | 0 | -26.7 | -18.5 | ||||||||||
cash-flows.row.inventory | 0 | 0 | -8.7 | -9.2 | ||||||||||
cash-flows.row.account-payables | 0 | 0 | 0.9 | 19.7 | ||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 1.7 | 0.6 | ||||||||||
cash-flows.row.other-non-cash-items | 0 | -62.1 | 504.6 | 290.6 | ||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -91.2 | -129.2 | ||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | -80.3 | -223.5 | ||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -39.2 | -40 | ||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 106.7 | 277.6 | ||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -106.7 | -277.6 | ||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -210.7 | -392.7 | ||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -162 | -174.4 | ||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 607.7 | 9.2 | ||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -29.9 | -88.6 | ||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -132.9 | -23 | ||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | -1.2 | 354.9 | ||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | 281.6 | 78.1 | ||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | -4.8 | -1.1 | ||||||||||
cash-flows.row.net-change-in-cash | 0 | 0 | 258 | -167.3 | ||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 644.7 | 644.7 | 386.7 | ||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 644.7 | 386.7 | 553.9 | ||||||||||
cash-flows.row.operating-cash-flow | 0 | 0 | 191.9 | 148.4 | ||||||||||
cash-flows.row.capital-expenditure | 0 | 0 | -91.2 | -129.2 | ||||||||||
cash-flows.row.free-cash-flow | 0 | 0 | 100.6 | 19.2 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1924 | 1731.9 | 1112.6 | ||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1381.5 | 1366.6 | 803.1 | ||||||||||
income-statement-row.row.gross-profit | 0 | 542.5 | 365.3 | 309.4 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | 0 | 5 | 0.6 | 0.3 | ||||||||||
income-statement-row.row.operating-expenses | 0 | 426 | 389.8 | 311.8 | ||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1807.5 | 1756.3 | 1114.9 | ||||||||||
income-statement-row.row.interest-income | 0 | 19.9 | 7.1 | 4.5 | ||||||||||
income-statement-row.row.interest-expense | 0 | 18.1 | 19.7 | 13 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 4.7 | -24.6 | 18.6 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | 0 | 5 | 0.6 | 0.3 | ||||||||||
income-statement-row.row.total-operating-expenses | 0 | 4.7 | -24.6 | 18.6 | ||||||||||
income-statement-row.row.interest-expense | 0 | 18.1 | 19.7 | 13 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 220.7 | 223.7 | 148.6 | ||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 0 | 116.4 | -24.4 | -2.3 | ||||||||||
income-statement-row.row.income-before-tax | 0 | 121.1 | -49 | 16.2 | ||||||||||
income-statement-row.row.income-tax-expense | 0 | 37.9 | 35 | 10.6 | ||||||||||
income-statement-row.row.net-income | 0 | 62 | -21.9 | 21.9 |
Dažnai užduodami klausimai
Kas yra C-MER Eye Care Holdings Limited (3309.HK) bendras turtas?
C-MER Eye Care Holdings Limited (3309.HK) bendras turtas yra 2748635000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.282.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 0.215.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.032.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.060.
Kas yra C-MER Eye Care Holdings Limited (3309.HK) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 61998000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 362990000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 426032000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.